Business
Oxygenta Pharmaceutical Limited Press Release Jul 21 2025
Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30.06.2025.
About this update from Oxygenta Pharmaceutical Limited
[{"type":"text","content":" Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30.06.2025.View Attachment","length":293,"tagName":"div"}]